Organic Letters
Letter
Scheme 7. Mechanistic Proposal
ACKNOWLEDGMENTS
■
We are grateful for the financial support from the Natural
Science Foundation of China (21432009, 21672200,
21472177, and 21772185) and for the assistance of the
product characterization from the Chemistry Experiment
Teaching Center of University of Science and Technology of
China. This work was supported by the Strategic Priority
Research Program of the Chinese Academy of Sciences, Grant
XDB20000000.
REFERENCES
■
(1) Selected reviews: (a) Wille, U. Chem. Rev. 2013, 113, 813.
(b) Chinchilla, R.; Najera, C. Chem. Rev. 2014, 114, 1783. (c) Yoshida,
H. ACS Catal. 2016, 6, 1799.
́
that when the allene intermediate E reacts with sulfonyls, the
final product can be obtained with excellent stereoselectivity
because of the influence of steric hindrance. We noted that 2n,
which had no methyl group adjacent to the hydrozone
functional group, can also be employed in this reaction. This
implied that the steric hindrance between the phenyl group of
the alkyne and the sulfonyl group led to the stereoselectivity of
the product rather than that between the phenyl group and the
methyl group of the hydrozone. No ligands or additives are
required in this process.
In conclusion, we developed a novel one-step method for
the synthesis of α, β-disubstituted vinyl sulfones through the
cross-coupling of N-tosylhydrazones and terminal alkynes. This
reaction represents an unprecedented example for the geminal
difunctionalization of terminal alkynes in a stereoselective
manner. The method exhibits broad functional-group tolerance
and can be extended to a larger scale. Moreover, the use of
stable facile materials under mild conditions without any
additional ligands presents great potential in industrial
application. The proposed mechanism involved intermolecular
copper carbene migratory insertion of terminal alkynes and
sulfonyl anion addition. Research including further mechanistic
details and synthetic applications is underway in our laboratory
(2) (a) Truce, W. E.; Wolf, G. C. J. Org. Chem. 1971, 36, 1727.
(b) Liu, Z.-Q.; Wang, J.; Han, J.; Zhao, Y.; Zhou, B. Tetrahedron Lett.
2009, 50, 1240. (c) Biswas, S.; Maiti, S.; Jana, U. Eur. J. Org. Chem.
2009, 2009, 2354. (d) Li, X.; Shi, X.; Fang, M.; Xu, X. J. Org. Chem.
2013, 78, 9499. (e) Gao, Y.; Wu, W.; Huang, Y.; Huang, K.; Jiang, H.
Org. Chem. Front. 2014, 1, 361. (f) Zhang, P.; Ying, J.; Tang, G.; Zhao,
Y. Org. Chem. Front. 2017, 4, 2054. (g) Sun, Y.; Abdukader, A.; Lu,
D.; Zhang, H.; Liu, C. Green Chem. 2017, 19, 1255. (h) Xiang, Y.;
Kuang, Y.; Wu, J. Chem. - Eur. J. 2017, 23, 6996. (i) Wu, C.; Wang, Z.;
Hu, Z.; Zeng, F.; Zhang, X.-Y.; Cao, Z.; Tang, Z.; He, W.-M.; Xu, X.-
H. Org. Biomol. Chem. 2018, 16, 3177. (j) Zhang, B.-S.; Gao, L.-Y.;
Zhang, Z.; Wen, Y.-H.; Liang, Y.-M. Chem. Commun. 2018, 54, 1185.
(k) Liu, J.-J.; Huang, H.-Y.; Cheng, L.; Liu, Q.; Wang, D.; Liu, L. Org.
Biomol. Chem. 2018, 16, 899. (l) Qiu, G.; Zhou, K.; Gao, L.; Wu, J.
Org. Chem. Front. 2018, 5, 691.
(3) (a) Morinaga, A.; Nagao, K.; Ohmiya, H.; Sawamura, M. Angew.
Chem., Int. Ed. 2015, 54, 15859. (b) Krautwald, S.; Bezdek, M.-J.;
Chirik, P.-J. J. Am. Chem. Soc. 2017, 139, 3868.
(4) (a) Palmer, J. T.; Rasnick, D.; Klaus, J. L.; Bromme, D. J. Med.
Chem. 1995, 38, 3193. (b) Roush, W. R.; Gwaltney, S. L.; Cheng, J.;
Scheidt, K. A.; McKerrow, J. H.; Hansell, E. J. Am. Chem. Soc. 1998,
120, 10994. (c) Frankel, B. A.; Bentley, M.; Kruger, R. G.;
McCafferty, D. G. J. Am. Chem. Soc. 2004, 126, 3404. (d) Meadows,
D. C.; Gervay-Hague, J. Med. Res. Rev. 2006, 26, 793. (e) Meadows,
D. C.; Sanchez, T.; Neamati, N.; North, T. W.; Gervay-Hague, J.
Bioorg. Med. Chem. 2007, 15, 1127. (f) Dunny, E.; Doherty, W.;
Evans, P.; Malthouse, J. P.; Nolan, D.; Knox, A. S. J. Med. Chem. 2013,
56, 6638. (g) Woo, S. Y.; Kim, J. H.; Moon, M. K.; Han, S.; Yeon, S.
K.; Choi, J. W.; Jang, B. K.; Song, H. J.; Kang, Y. G.; Kim, J. W.; Lee,
J.; Kim, D. J.; Hwang, O.; Park, K. D. J. Med. Chem. 2014, 57, 1473.
(h) Doherty, W.; James, J.; Evans, P.; Martin, L.; Adler, N.; Nolan, D.;
Knox, A. Org. Biomol. Chem. 2014, 12, 7561. (i) Turnbull, A. P.;
Ioannidis, S.; Krajewski, W. W. Nature 2017, 550, 481.
ASSOCIATED CONTENT
* Supporting Information
■
S
The Supporting Information is available free of charge on the
Experimental procedures, characterization data, copies of
1H NMR, 13C NMR of new compounds, and crystallo-
graphic data for compound 3ac (PDF)
(5) (a) Fuchs, P. L.; Braish, T. F. Chem. Rev. 1986, 86, 903.
(b) Simpkins, N. S. Tetrahedron 1990, 46, 6951. (c) Najera, C.; Yus,
Accession Codes
M. Tetrahedron 1999, 55, 10547. (d) Enders, D.; Mu
G.; Runsink, J. Eur. J. Org. Chem. 2000, 2000, 879. (e) Alba, A.-N. R.;
̈
ller, S. F.; Raabe,
CCDC 1852379 contains the supplementary crystallographic
data for this paper. These data can be obtained free of charge
bridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
́
Companyo, X.; Rios, R. Chem. Soc. Rev. 2010, 39, 2018.
(6) (a) Chen, J.; Mao, J.; Zheng, Y.; Liu, D.; Rong, G.; Yan, H.;
Zhang, C.; Shi, D. Tetrahedron 2015, 71, 5059. (b) Qian, P.; Bi, M.;
Su, J.; Zha, Z.; Wang, Z. J. Org. Chem. 2016, 81, 4876. (c) Cai, S.; Xu,
Y.; Chen, D.; Li, L.; Chen, Q.; Huang, M.; Weng, W. Org. Lett. 2016,
18, 2990. (d) Wang, L.; Yue, H.; Yang, D.; Cui, H.; Zhu, M.; Wang, J.;
Wei, W.; Wang, H. J. Org. Chem. 2017, 82, 6857. (e) Kadari, L.;
Palakodety, R. K. L.; Yallapragada, P. Org. Lett. 2017, 19, 2580.
(7) Wang, H.; Lu, Q.; Chiang, C.-W.; Luo, Y.; Zhou, J.; Wang, G.;
Lei, A. Angew. Chem., Int. Ed. 2017, 56, 595.
AUTHOR INFORMATION
■
Corresponding Author
ORCID
(8) (a) Fan, W.; Su, J.; Shi, D.; Feng, B. Tetrahedron 2015, 71, 6740.
(b) Fan, W.; Xiang, Y.; Li, Z.; Wu, J. Org. Chem. Front. 2016, 3, 1493.
(c) Li, Y.; Xiang, Y.; Li, Z.; Wu, J. Org. Chem. Front. 2016, 3, 1493.
(d) Zheng, D.; Yu, J.; Wu, J. Angew. Chem., Int. Ed. 2016, 55, 1.
Notes
(9) García-Domínguez, A.; Mu
Ed. 2017, 56, 9949.
̈
ller, S.; Nevado, C. Angew. Chem., Int.
The authors declare no competing financial interest.
D
Org. Lett. XXXX, XXX, XXX−XXX